Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial Healthcare System in Pembroke Pines, Florida. In this episode, we explore the latest advances and what the future holds for CAR T-cell therapy.   

This comprehensive view of CAR T-cell therapy will give blood cancer patients and their families hope. Through the utilization of targeted therapies, we can now see a future filled with better outcomes and potential cures.

Mentioned on this episode: 

• CAR T-cell Therapy
  
  
• Cytokine release syndrome
  
  
• Stem Cell Transplant
  
  
• Graft-Vs-Host Disease (GVHD)
  
  
• Clinical Trial Support Center
  

Additional LLS Support Resources: 

• Information Specialists 
  
  
• Free telephone/web patient programs 
  
  
• Free booklets 
  
  
• Financial support
  
  
• Young Adult Resources
  
  
• Survivorship Workbook
  
  
• Online chats 
  
  
• Caregiver support 
  
  
• LLS Community 
  
  
• Support groups 
  
  
• Patti Robinson Kaufmann First Connection Program 
  
  
• Free Nutrition Consultations
  

Support for this program is provided by: Allogene Therapeutics; Bristol Myers Squibb; CRISPR Therapeutics Ltd; Janssen Oncology & Legend Biotech; Kite, A Gilead Company and Novartis Pharmaceuticals Corp.

The post Attacking the Cancer Cell: Advances in CAR T-Cell Therapy appeared first on The Bloodline with LLS.